carvedilol has been researched along with enalapril in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (6.12) | 18.2507 |
| 2000's | 29 (59.18) | 29.6817 |
| 2010's | 13 (26.53) | 24.3611 |
| 2020's | 4 (8.16) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Karlberg, BE; Ostergren, J; Storstein, L; Tibblin, G | 1 |
| Chatterjee, K | 1 |
| Cleophas, TJ; van de Luit, L; van der Meulen, J; Zwinderman, AH | 1 |
| Berger, R; Frey, B; Hülsmann, M; Pacher, R; Stanek, B; Strecker, K | 1 |
| Wood, AJ | 1 |
| Cosín Aguilar, J; Hernándiz Martínez, A | 1 |
| Bertsch, T; Feuring, M; Jester, I; Kugler, I; Schmidt, BM; Tillmann, HC; Wehling, M | 1 |
| Isnard, R | 1 |
| Baiano, A; de Cristofaro, A; Del Forno, D; Giallauria, F; Paragliola, T; Rossi, M; Vigorito, C | 1 |
| Bobbio, M; Hildebrandt, P; Jaarsma, W; Komajda, M; Lutiger, B; Remme, WJ; Riegger, G; Rydén, L; Scherhag, A; Soler-Soler, J | 1 |
| Bobbio, M; Hildebrandt, P; Jaarsma, W; Komajda, M; Lutiger, B; Madeira, H; Remme, WJ; Riegger, G; Rydén, L; Scherhag, A; Soler-Soler, J; Thygesen, K | 1 |
| Abdulla, J; Køber, L; Torp-Pedersen, C | 1 |
| Belousov, IuB; Khanina, NIu; Upnitskiĭ, AA | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Devereux, RB; Krauser, DG | 1 |
| Calabrò, R; Natale, F; Tedesco, MA | 1 |
| Hirooka, K; Nakayama, D; Saito, M; Takada, M; Yasumura, Y | 1 |
| Botoni, FA; Dantas, JB; Ferreira, CS; Okonko, DO; Oliveira, BM; Pinto, AS; Poole-Wilson, PA; Reis, AM; Ribeiro, AL; Rocha, MO; Tavares, WC; Teixeira, AL; Teixeira, MM | 1 |
| Kawana, M; Shimamoto, K | 1 |
| Bacal, F; Bocchi, EA; Chizzola, PR; Guimarães, GV; Issa, VS; Mangini, S; Moreira, SF; Pires, PV; Silva, CP; Souza, GE | 1 |
| Fujiwara, M; Harada, M; Hosoda, K; Kawakami, R; Kinoshita, H; Kotani, H; Kuwahara, K; Nakagawa, Y; Nakanishi, M; Nakao, K; Tadamura, E; Ueshima, K; Usami, S | 1 |
| Remme, WJ | 2 |
| Gustafsson, F; Hildebrandt, PR; Remme, WJ; Riegger, GA; Rosenberg, J | 1 |
| Asif, H; Chaudhari, MP; Crossland, DS; Kirk, RC; O'Sullivan, JJ; Roche, SL | 1 |
| de Boer, RA; van Veldhuisen, DJ | 1 |
| Altieri, PI; Crespo, MJ; Cruz, N; Escobales, N | 1 |
| Bocchi, EA; Carvalho, VO; Guimarães, GV | 1 |
| Borovkov, NN; Iarkova, NA | 1 |
| Cardinale, D; Cipolla, CM; Civelli, M; Colombo, A; Colombo, N; De Giacomi, G; Fiorentini, C; Lamantia, G; Rubino, M; Veglia, F | 1 |
| Bosch, X; de Caralt, TM; Domènech, A; Esteve, J; Monzó, M; Morales-Ruiz, M; Ortiz, JT; Perea, RJ; Rovira, M; Sitges, M | 1 |
| Dvorák, J; Kupec, J; Málek, F; Neuzil, P; Petrů, J; Sedivá, L; Táborský, M; Vondráková, D | 1 |
| Edvardsen, T; Skulstad, H; Smiseth, OA | 1 |
| Bosch, X; de Caralt, TM; Domènech, A; Esteve, J; Monzó, M; Morales-Ruiz, M; Ortiz-Pérez, JT; Perea, RJ; Rovira, M; Sitges, M | 1 |
| Gaciong, Z; Judycki, J; Korecki, J; Lewandowski, J; Możeńska, O; Rogowski, K; Sieczych, A; Sinski, M; Symonides, B | 1 |
| Woo, HH | 1 |
| Fukami, N; Nakamura, K | 1 |
| Akabuogu, EU; Phyu, SM; Smith, TA | 1 |
| Ishikawa, K; Kagamu, H; Kaira, K; Shinomiya, S; Yamaguchi, O | 1 |
| Burckhardt, BB; Gangnus, T | 1 |
| Imamura, T; Kinugawa, K; Tanaka, S; Ueno, H | 1 |
| DalirAkbari, N; Farshi, A; Khalili, M; Mahmoudinezhad, M; Zomorrodi, A | 1 |
6 review(s) available for carvedilol and enalapril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Clinical trials on heart failure].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Calcium Channel Blockers; Carbazoles; Cardiotonic Agents; Carvedilol; Clinical Trials as Topic; Death, Sudden, Cardiac; Diuretics; Enalapril; Heart Failure; Humans; Middle Aged; Multicenter Studies as Topic; Prognosis; Propanolamines; Quality of Life; Risk Factors; Time Factors; Vasodilator Agents | 2001 |
[Congestive heart failure and acute myocardial infarction: latest trials with beta-blocking agents].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Confidence Intervals; Death, Sudden, Cardiac; Enalapril; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Meta-Analysis as Topic; Middle Aged; Myocardial Infarction; Placebos; Propanolamines; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2002 |
Methods of assessing the functional status of patients with left ventricular systolic dysfunction in interventional studies: can brain natriuretic peptide measurement be used as surrogate for the traditional methods?
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Carbazoles; Carvedilol; Clinical Trials as Topic; Data Collection; Drug Administration Schedule; Enalapril; Exercise Test; Exercise Tolerance; Health Status; Heart Failure; Humans; Imidazolidines; Meta-Analysis as Topic; Metoprolol; Natriuretic Peptide, Brain; Propanolamines; Quality of Life; Statistics as Topic; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan | 2006 |
Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Defibrillators, Implantable; Disease Progression; Enalapril; Heart Failure; Humans; Perindopril; Propanolamines; Treatment Outcome; Ventricular Remodeling | 2007 |
15 trial(s) available for carvedilol and enalapril
| Article | Year |
|---|---|
Quality of life in hypertensive patients treated with either carvedilol or enalapril.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Cough; Double-Blind Method; Enalapril; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Propanolamines; Quality of Life | 1996 |
Daytime-selective antihypertensive activity of celiprolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Carbazoles; Cardiac Output, Low; Carvedilol; Celiprolol; Cerebrovascular Circulation; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Enalapril; Female; Heart Rate; Humans; Hypertension; Hypotension; Male; Middle Aged; Placebos; Propanolamines; Sympathetic Nervous System | 1999 |
Impact of pharmacotherapy on lymphocyte volumes and activity of the Na+/H+ exchanger in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Cell Size; Digoxin; Diuretics; Drug Interactions; Enalapril; Female; Heart Failure; Humans; Leukocytes, Mononuclear; Lymphocytes; Male; Middle Aged; Propanolamines; Sodium-Hydrogen Exchangers; Treatment Outcome | 2001 |
The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Ventricular Remodeling | 2004 |
Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Carbazoles; Carvedilol; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hospitalization; Humans; Kidney; Male; Middle Aged; Propanolamines; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling; Withholding Treatment | 2004 |
[Effect of long-term therapy with contemporary drugs on diastolic cardiac function in patients with chronic heart failure].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Diastole; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Enalapril; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Propanolamines; Time Factors; Treatment Outcome; Ventricular Function, Left | 2005 |
Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carbazoles; Cardiovascular Diseases; Carvedilol; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Losartan; Male; Middle Aged; Propanolamines; Ultrasonography | 2006 |
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Chagas Cardiomyopathy; Chronic Disease; Double-Blind Method; Enalapril; Female; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Propanolamines; Renin-Angiotensin System; Spironolactone | 2007 |
Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Carbazoles; Carvedilol; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Enalapril; Europe; Female; Heart Failure, Systolic; Hospitalization; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Propanolamines; Proportional Hazards Models; Risk Assessment; Time Factors; Treatment Outcome | 2008 |
[Drug therapy of diastolic cardiac insufficiency in patients with type 2 diabetes and concomitant essential arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Carbazoles; Carvedilol; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography, Doppler, Color; Enalapril; Female; Follow-Up Studies; Heart Failure, Diastolic; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Propanolamines; Retrospective Studies; Treatment Outcome | 2009 |
Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Antineoplastic Agents; Carbazoles; Carvedilol; Cohort Studies; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Neoplasms; Propanolamines; Recovery of Function; Stroke Volume; Treatment Outcome | 2010 |
Prevention of chemotherapy-induced left ventricular dysfunction with enalapril and carvedilol: rationale and design of the OVERCOME trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propanolamines; Sample Size; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult | 2011 |
Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted t
Topics: Adult; Antineoplastic Agents; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography, Doppler; Enalapril; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Middle Aged; Propanolamines; Reference Values; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2013 |
Beneficial influence of carvedilol on urologic indices in patients with hypertension and benign prostatic hyperplasia: results of a randomized, crossover study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Cross-Over Studies; Double-Blind Method; Enalapril; Humans; Hypertension; Male; Middle Aged; Propanolamines; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatism; Severity of Illness Index; Surveys and Questionnaires; Urodynamics | 2013 |
A Randomized Crossover Pilot Study Examining the Effect of Carvedilol and Terazosin plus Enalapril on Urinary Symptoms of Patients with Hypertension and Benign Prostatic Hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Antihypertensive Agents; Carvedilol; Cross-Over Studies; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Male; Middle Aged; Pilot Projects; Prazosin; Prostatic Hyperplasia; Single-Blind Method | 2021 |
28 other study(ies) available for carvedilol and enalapril
| Article | Year |
|---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Heart failure therapy in evolution.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiac Output, Low; Cardiology; Carvedilol; Enalapril; Exercise Test; Humans; Mortality; Propanolamines | 1996 |
Experience with beta-blocker therapy in patients with advanced heart failure evaluated for HTx.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Propanolamines; Retrospective Studies; Risk Assessment; Survival Rate | 2000 |
Racial differences in the response to drugs--pointers to genetic differences.
Topics: Adrenergic Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Cytochrome P-450 Enzyme System; Enalapril; Heart Failure; Hospitalization; Humans; Mortality; Propanolamines; Racial Groups | 2001 |
[Beta blockers and ACE inhibitors In heart failure to be combined at the beginning!].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Enalapril; Follow-Up Studies; Heart Failure; Humans; Multicenter Studies as Topic; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors; Ventricular Remodeling | 2002 |
[Cardiac rehabilitation in a HIV-patient treated with protease inhibitors].
Topics: Adult; Aspirin; Carbazoles; Carvedilol; Cholesterol; Coronary Angiography; Diet Therapy; Drug Therapy, Combination; Enalapril; Exercise Therapy; HIV Infections; Humans; Male; Myocardial Infarction; Nitrates; Pravastatin; Propanolamines; Protease Inhibitors; Treatment Outcome; Triglycerides | 2003 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil.
Topics: Adult; Aged; Aged, 80 and over; Benzimidazoles; Biphenyl Compounds; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Female; Furosemide; Heart Failure; Humans; Hyperkalemia; Male; Middle Aged; Potassium; Propanolamines; Retrospective Studies; Spironolactone; Tetrazoles | 2006 |
[The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Propanolamines; Research Design; Ventricular Remodeling | 2007 |
Heart failure treatment profile at the beta blockers era.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Propanolamines; Severity of Illness Index | 2007 |
Images in cardiovascular medicine. Mitochondrial cardiomyopathy evaluated with cardiac magnetic resonance.
Topics: Aged; Biopsy; Carbazoles; Cardiomyopathies; Carvedilol; Coenzymes; Coronary Angiography; Enalapril; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Mitochondria, Heart; Mitochondrial Diseases; Propanolamines; Ubiquinone | 2007 |
Recovery of heart function in children with acute severe heart failure.
Topics: Acute Disease; Captopril; Carbazoles; Cardiotonic Agents; Carvedilol; Child; Child, Preschool; Databases, Factual; Digoxin; Enalapril; Enoximone; Female; Heart Failure; Heart Function Tests; Humans; Infant; Infant, Newborn; Male; Propanolamines; Treatment Outcome | 2008 |
ACE-inhibitors, beta-blockers or the combination in heart failure: is it just an A-B-C ? : editorial to: effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Carbazoles; Carvedilol; Chronic Disease; Drug Therapy, Combination; Enalapril; Heart Failure, Systolic; Humans; Natriuretic Peptide, Brain; Peptide Fragments; Propanolamines; Risk Assessment; Time Factors; Treatment Outcome | 2008 |
Enalapril and losartan are more effective than carvedilol in preventing dilated cardiomyopathy in the Syrian cardiomyopathic hamster.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Carbazoles; Cardiac Output; Cardiomyopathy, Dilated; Carvedilol; Cricetinae; Disease Models, Animal; Disease Progression; Enalapril; Losartan; Male; Mesocricetus; Propanolamines; Renin-Angiotensin System; Stroke Volume; Time Factors; Ultrasonography; Ventricular Function, Left | 2008 |
Beta-blockade as first-line therapy in the elderly heart failure patient--the proper approach or asking for trouble?
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Professional Practice; Propanolamines | 2008 |
The relationship between heart rate reserve and oxygen uptake reserve in heart failure patients on optimized and non-optimized beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Losartan; Male; Middle Aged; Oxygen Consumption; Propanolamines | 2008 |
Critical evaluation of the optimal medical therapy in the cardiac resynchronization therapy candidates--single centre experience.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Carbazoles; Cardiac Resynchronization Therapy; Carvedilol; Defibrillators, Implantable; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Propanolamines | 2011 |
Cardioprotection during chemotherapy: need for faster transfer of knowledge from cardiology to oncology and role for a cardio-oncologist.
Topics: Antineoplastic Agents; Carbazoles; Carvedilol; Enalapril; Female; Hematologic Neoplasms; Humans; Male; Propanolamines; Ventricular Dysfunction, Left | 2013 |
Editorial comment.
Topics: Antihypertensive Agents; Carbazoles; Carvedilol; Enalapril; Humans; Hypertension; Male; Propanolamines; Prostatism; Urodynamics | 2013 |
Altered responses to vasopressors of a patient medicated with carvedilol, pilsicainide and enalapril.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbazoles; Carvedilol; Drug Interactions; Enalapril; Humans; Hypotension; Lidocaine; Male; Middle Aged; Propanolamines; Vasoconstrictor Agents | 2014 |
Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbazoles; Cardiomyopathies; Cardiotonic Agents; Cardiovascular Agents; Carvedilol; Cell Line, Tumor; Cell Survival; Dexrazoxane; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Enalapril; Female; Fluorodeoxyglucose F18; Humans; Metformin; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Trastuzumab | 2016 |
Osimertinib induced cardiomyopathy: A case report.
Topics: Acrylamides; Adenocarcinoma of Lung; Adrenergic beta-Antagonists; Afatinib; Aged; Angiotensin-Converting Enzyme Inhibitors; Aniline Compounds; Cardiomyopathies; Carvedilol; Diuretics; Enalapril; Female; Furosemide; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Recurrence; Treatment Outcome; Withholding Treatment | 2020 |
Low-volume LC-MS/MS method for the pharmacokinetic investigation of carvedilol, enalapril and their metabolites in whole blood and plasma: Application to a paediatric clinical trial.
Topics: Adolescent; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carvedilol; Child; Child, Preschool; Chromatography, Liquid; Enalapril; Humans; Infant; Infant, Newborn; Prospective Studies; Reproducibility of Results; Tandem Mass Spectrometry | 2021 |
MitraClip or Ventricular Assist Device?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Resynchronization Therapy; Carvedilol; Clinical Decision-Making; Disease Progression; Enalapril; Female; Heart Failure; Heart-Assist Devices; Hospitalization; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Mitral Valve Annuloplasty; Mitral Valve Insufficiency; Natriuretic Peptide, Brain; Oxygen Consumption; Patient Selection; Pulmonary Wedge Pressure; Recurrence; Severity of Illness Index; Spironolactone; Treatment Outcome | 2020 |